Genomes and Genes

Species

Massimo Negrini

Summary

Affiliation: University of Ferrara
Country: Italy

Publications

  1. Ferracin M, Salamon I, Lupini L, Miotto E, Sabbioni S, Negrini M. Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR. J Vis Exp. 2016;: pubmed publisher
    ..Here, we describe how performing this technique to assess miRNA amount in biological fluids, such as plasma and serum, is both feasible and effective. ..
  2. request reprint
    Negrini M, Gramantieri L, Sabbioni S, Croce C. microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem. 2011;11:500-21 pubmed
    ..In this context, the liver represents an organ of election to test therapeutic possibilities associated with miRNAs. ..
  3. Lupini L, Bassi C, Mlcochova J, Musa G, Russo M, Vychytilova Faltejskova P, et al. Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC Cancer. 2015;15:808 pubmed publisher
    ....
  4. Shankaraiah R, Veronese A, Sabbioni S, Negrini M. Non-coding RNAs in the reprogramming of glucose metabolism in cancer. Cancer Lett. 2018;419:167-174 pubmed publisher
    ....
  5. Negrini M. Change of Title: Microarrays Becomes High-Throughput. High Throughput. 2017;6: pubmed publisher
    ..MDPI's journal Microarrays released its first volume in 2012. Since then, the journal has published 129 articles on the topic of microarrays, including their applications, analysis and new developments. [...]. ..
  6. Negrini M, Nicoloso M, Calin G. MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol. 2009;21:470-9 pubmed publisher
    ..New diagnostic classifiers based on miRNAs will soon be available for medical practitioners and, even more importantly, miRNAs may become novel anti-cancer tools. ..
  7. Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, et al. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res. 2014;20:4141-53 pubmed publisher
    ..Collectively, this information can be used for developing miRNA-based therapeutic strategies in CLL. ..

Detail Information

Publications7

  1. Ferracin M, Salamon I, Lupini L, Miotto E, Sabbioni S, Negrini M. Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR. J Vis Exp. 2016;: pubmed publisher
    ..Here, we describe how performing this technique to assess miRNA amount in biological fluids, such as plasma and serum, is both feasible and effective. ..
  2. request reprint
    Negrini M, Gramantieri L, Sabbioni S, Croce C. microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem. 2011;11:500-21 pubmed
    ..In this context, the liver represents an organ of election to test therapeutic possibilities associated with miRNAs. ..
  3. Lupini L, Bassi C, Mlcochova J, Musa G, Russo M, Vychytilova Faltejskova P, et al. Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC Cancer. 2015;15:808 pubmed publisher
    ....
  4. Shankaraiah R, Veronese A, Sabbioni S, Negrini M. Non-coding RNAs in the reprogramming of glucose metabolism in cancer. Cancer Lett. 2018;419:167-174 pubmed publisher
    ....
  5. Negrini M. Change of Title: Microarrays Becomes High-Throughput. High Throughput. 2017;6: pubmed publisher
    ..MDPI's journal Microarrays released its first volume in 2012. Since then, the journal has published 129 articles on the topic of microarrays, including their applications, analysis and new developments. [...]. ..
  6. Negrini M, Nicoloso M, Calin G. MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol. 2009;21:470-9 pubmed publisher
    ..New diagnostic classifiers based on miRNAs will soon be available for medical practitioners and, even more importantly, miRNAs may become novel anti-cancer tools. ..
  7. Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, et al. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res. 2014;20:4141-53 pubmed publisher
    ..Collectively, this information can be used for developing miRNA-based therapeutic strategies in CLL. ..